These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas. Han MH; Baek JM; Min KW; Cheong JH; Ryu JI; Won YD; Kwon MJ; Koh SH BMC Neurol; 2023 May; 23(1):183. PubMed ID: 37149563 [TBL] [Abstract][Full Text] [Related]
4. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Liang Y; Bollen AW; Aldape KD; Gupta N BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952 [TBL] [Abstract][Full Text] [Related]
5. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis. Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733 [TBL] [Abstract][Full Text] [Related]
6. Integrating multiple-level molecular data to infer the distinctions between glioblastoma and lower-grade glioma. Zhang X; Lu X; Liu Z; Guan R; Wang J; Kong X; Chen L; Bo C; Tian K; Xu S; Bai M; Zhang H; Li J; Wang L; Shen J; Guo M Int J Cancer; 2019 Aug; 145(4):952-961. PubMed ID: 30694558 [TBL] [Abstract][Full Text] [Related]
7. Identification of potential biomarkers related to glioma survival by gene expression profile analysis. Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447 [TBL] [Abstract][Full Text] [Related]
9. Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts. Li D; Li S; Xue AZ; Smith Callahan LA; Liu Y Medicine (Baltimore); 2020 Mar; 99(12):e18815. PubMed ID: 32195924 [TBL] [Abstract][Full Text] [Related]
10. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas. Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770 [TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma. Biterge-Sut B Arq Neuropsiquiatr; 2020 Jan; 78(1):34-38. PubMed ID: 32074192 [TBL] [Abstract][Full Text] [Related]
12. ACTC1 as an invasion and prognosis marker in glioma. Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of the circadian clock network correlates with tumour progression in gliomas. Petkovic M; Yalçin M; Heese O; Relógio A BMC Med Genomics; 2023 Jul; 16(1):154. PubMed ID: 37400829 [TBL] [Abstract][Full Text] [Related]
14. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series. Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405 [TBL] [Abstract][Full Text] [Related]
15. 'Cut from the same cloth': Shared microsatellite variants among cancers link to ectodermal tissues-neural tube and crest cells. Karunasena E; Mciver LJ; Bavarva JH; Wu X; Zhu H; Garner HR Oncotarget; 2015 Sep; 6(26):22038-47. PubMed ID: 26246470 [TBL] [Abstract][Full Text] [Related]
16. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas. Garcia JL; Perez-Caro M; Gomez-Moreta JA; Gonzalez F; Ortiz J; Blanco O; Sancho M; Hernandez-Rivas JM; Gonzalez-Sarmiento R; Sanchez-Martin M BMC Cancer; 2010 Aug; 10():454. PubMed ID: 20735813 [TBL] [Abstract][Full Text] [Related]
18. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas. Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139 [TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma. Cho SY; Kim S; Kim G; Singh P; Kim DW Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592 [TBL] [Abstract][Full Text] [Related]
20. Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining. Faried A; Hermanto Y; Tjahjono FP; Valentino A; Arifin MZ World Neurosurg; 2020 Mar; 135():e137-e163. PubMed ID: 31785437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]